[(1R,9R,16Z,19R,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,22,24,25-pentahydroxy-23-[(3S)-3-hydroxyoct-1-enyl]-4,6,12,20-tetraoxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 17-methyloctadecanoate

C51H87N3O18P2 — CID 157002118

IUPAC[(1R,9R,16Z,19R,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,22,24,25-pentahydroxy-23-[(3S)-3-hydroxyoct-1-enyl]-4,6,12,20-tetraoxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 17-methyloctadecanoate
SMILESCCCCC[C@H](O)C=C[C@@H]1[C@H](O)[C@H](O)[C@H]2COP(=O)(O)OP(=O)(O)OC[C@H](OC(=O)CCCCCCCCCCCCCCCC(C)C)COC(=O)CCC/C=C\C[C@@H](C(=O)C[C@H]1O)[C@H](n1ccc(N)nc1=O)O2
InChIInChI=1S/C51H87N3O18P2/c1-4-5-19-25-38(55)29-30-40-42(56)33-43(57)41-26-21-17-18-22-27-46(58)67-34-39(70-47(59)28-23-16-14-12-10-8-6-7-9-11-13-15-20-24-37(2)3)35-68-73(63,64)72-74(65,66)69-36-44(49(61)48(40)60)71-50(41)54-32-31-45(52)53-51(54)62/h17,21,29-32,37-42,44,48-50,55-56,60-61H,4-16,18-20,22-28,33-36H2,1-3H3,(H,63,64)(H,65,66)(H2,52,53,62)/b21-17-,30-29?/t38-,39+,40-,41-,42+,44+,48-,49+,50+/m0/s1
InChIKeyOPCRCXPVZGHNRK-NTKAPVQKSA-N
MW1092.21 g/mol
LogP7.84
Rot. Bonds24

About [(1R,9R,16Z,19R,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,22,24,25-pentahydroxy-23-[(3S)-3-hydroxyoct-1-enyl]-4,6,12,20-tetraoxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 17-methyloctadecanoate

[(1R,9R,16Z,19R,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,22,24,25-pentahydroxy-23-[(3S)-3-hydroxyoct-1-enyl]-4,6,12,20-tetraoxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 17-methyloctadecanoate (PubChem CID 157002118) has the molecular formula C51H87N3O18P2 and a molecular weight of 1092.21 g/mol. Its IUPAC name is [(1R,9R,16Z,19R,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,22,24,25-pentahydroxy-23-[(3S)-3-hydroxyoct-1-enyl]-4,6,12,20-tetraoxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 17-methyloctadecanoate.

Molecular Properties

Compound Name[(1R,9R,16Z,19R,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,22,24,25-pentahydroxy-23-[(3S)-3-hydroxyoct-1-enyl]-4,6,12,20-tetraoxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 17-methyloctadecanoate
PubChem CID157002118
Molecular FormulaC51H87N3O18P2
Molecular Weight1092.21 g/mol
Exact Mass1091.55
IUPAC Name[(1R,9R,16Z,19R,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,22,24,25-pentahydroxy-23-[(3S)-3-hydroxyoct-1-enyl]-4,6,12,20-tetraoxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 17-methyloctadecanoate
SMILESCCCCC[C@H](O)C=C[C@@H]1[C@H](O)[C@H](O)[C@H]2COP(=O)(O)OP(=O)(O)OC[C@H](OC(=O)CCCCCCCCCCCCCCCC(C)C)COC(=O)CCC/C=C\C[C@@H](C(=O)C[C@H]1O)[C@H](n1ccc(N)nc1=O)O2
InChIInChI=1S/C51H87N3O18P2/c1-4-5-19-25-38(55)29-30-40-42(56)33-43(57)41-26-21-17-18-22-27-46(58)67-34-39(70-47(59)28-23-16-14-12-10-8-6-7-9-11-13-15-20-24-37(2)3)35-68-73(63,64)72-74(65,66)69-36-44(49(61)48(40)60)71-50(41)54-32-31-45(52)53-51(54)62/h17,21,29-32,37-42,44,48-50,55-56,60-61H,4-16,18-20,22-28,33-36H2,1-3H3,(H,63,64)(H,65,66)(H2,52,53,62)/b21-17-,30-29?/t38-,39+,40-,41-,42+,44+,48-,49+,50+/m0/s1
InChIKeyOPCRCXPVZGHNRK-NTKAPVQKSA-N
XLogP7.84
TPSA323.02 Ų
H-Bond Donors7
H-Bond Acceptors19
Rotatable Bonds24
Heavy Atoms74
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001092.21
LogP ≤ 57.84
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze [(1R,9R,16Z,19R,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,22,24,25-pentahydroxy-23-[(3S)-3-hydroxyoct-1-enyl]-4,6,12,20-tetraoxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 17-methyloctadecanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1R,9R,16Z,19R,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,22,24,25-pentahydroxy-23-[(3S)-3-hydroxyoct-1-enyl]-4,6,12,20-tetraoxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 17-methyloctadecanoate?
The IUPAC name of [(1R,9R,16Z,19R,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,22,24,25-pentahydroxy-23-[(3S)-3-hydroxyoct-1-enyl]-4,6,12,20-tetraoxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 17-methyloctadecanoate (CID 157002118) is [(1R,9R,16Z,19R,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,22,24,25-pentahydroxy-23-[(3S)-3-hydroxyoct-1-enyl]-4,6,12,20-tetraoxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 17-methyloctadecanoate.
What is the SMILES notation for [(1R,9R,16Z,19R,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,22,24,25-pentahydroxy-23-[(3S)-3-hydroxyoct-1-enyl]-4,6,12,20-tetraoxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 17-methyloctadecanoate?
The canonical SMILES for [(1R,9R,16Z,19R,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,22,24,25-pentahydroxy-23-[(3S)-3-hydroxyoct-1-enyl]-4,6,12,20-tetraoxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 17-methyloctadecanoate is CCCCC[C@H](O)C=C[C@@H]1[C@H](O)[C@H](O)[C@H]2COP(=O)(O)OP(=O)(O)OC[C@H](OC(=O)CCCCCCCCCCCCCCCC(C)C)COC(=O)CCC/C=C\C[C@@H](C(=O)C[C@H]1O)[C@H](n1ccc(N)nc1=O)O2.
What is the InChIKey of [(1R,9R,16Z,19R,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,22,24,25-pentahydroxy-23-[(3S)-3-hydroxyoct-1-enyl]-4,6,12,20-tetraoxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 17-methyloctadecanoate?
The InChIKey is OPCRCXPVZGHNRK-NTKAPVQKSA-N. The full InChI is InChI=1S/C51H87N3O18P2/c1-4-5-19-25-38(55)29-30-40-42(56)33-43(57)41-26-21-17-18-22-27-46(58)67-34-39(70-47(59)28-23-16-14-12-10-8-6-7-9-11-13-15-20-24-37(2)3)35-68-73(63,64)72-74(65,66)69-36-44(49(61)48(40)60)71-50(41)54-32-31-45(52)53-51(54)62/h17,21,29-32,37-42,44,48-50,55-56,60-61H,4-16,18-20,22-28,33-36H2,1-3H3,(H,63,64)(H,65,66)(H2,52,53,62)/b21-17-,30-29?/t38-,39+,40-,41-,42+,44+,48-,49+,50+/m0/s1.
What are the key properties of [(1R,9R,16Z,19R,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,22,24,25-pentahydroxy-23-[(3S)-3-hydroxyoct-1-enyl]-4,6,12,20-tetraoxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 17-methyloctadecanoate?
[(1R,9R,16Z,19R,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,22,24,25-pentahydroxy-23-[(3S)-3-hydroxyoct-1-enyl]-4,6,12,20-tetraoxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 17-methyloctadecanoate has a molecular weight of 1092.21 g/mol, XLogP of 7.84, 24 rotatable bonds, 7 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for [(1R,9R,16Z,19R,22R,23S,24S,25S,27R)-27-(4-amino-2-oxopyrimidin-1-yl)-4,6,22,24,25-pentahydroxy-23-[(3S)-3-hydroxyoct-1-enyl]-4,6,12,20-tetraoxo-3,5,7,11,26-pentaoxa-4λ5,6λ5-diphosphabicyclo[17.6.2]heptacos-16-en-9-yl] 17-methyloctadecanoate is sourced from PubChem (CID 157002118), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).